{"title":"Trauma-Induced Coagulopathy: A Review of Specific Molecular Mechanisms.","authors":"Andrea Capponi, Carlo Rostagno","doi":"10.3390/diagnostics15111435","DOIUrl":null,"url":null,"abstract":"<p><p>Trauma remains a leading cause of death and disability in adults, and about 20% of deaths occur due to intractable bleeding. Trauma-induced coagulopathy (TIC) is a complex hemostatic disorder characterized by an abnormal coagulation response, which can manifest as either a hypo-coagulable state, leading to excessive bleeding, or a hypercoagulable state, resulting in thromboembolic events and multiple organ failure. Early diagnosis and correction of hypocoagulability may be lifesaving. Replacement of coagulation factors using blood components as well as counteracting enhanced fibrinolysis with tranexamic acid in association with a strategy of damage control are the current practices in the management of TIC. Nevertheless, the improved comprehension of the several mechanisms involved in the development of TIC might offer space for a tailored treatment with improvement of clinical outcome. This review aims to outline the pathophysiology of TIC and evaluate both established and emerging management strategies. A thorough literature review was made with a specific emphasis on articles discussing the molecular mechanisms of trauma-induced coagulopathy. We utilized PubMed, Scopus, and Web of Science with the main search terms \"trauma-induced coagulopathy\", \"molecular mechanisms\", and \"coagulation pathways\".</p>","PeriodicalId":11225,"journal":{"name":"Diagnostics","volume":"15 11","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12155344/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diagnostics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/diagnostics15111435","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Trauma remains a leading cause of death and disability in adults, and about 20% of deaths occur due to intractable bleeding. Trauma-induced coagulopathy (TIC) is a complex hemostatic disorder characterized by an abnormal coagulation response, which can manifest as either a hypo-coagulable state, leading to excessive bleeding, or a hypercoagulable state, resulting in thromboembolic events and multiple organ failure. Early diagnosis and correction of hypocoagulability may be lifesaving. Replacement of coagulation factors using blood components as well as counteracting enhanced fibrinolysis with tranexamic acid in association with a strategy of damage control are the current practices in the management of TIC. Nevertheless, the improved comprehension of the several mechanisms involved in the development of TIC might offer space for a tailored treatment with improvement of clinical outcome. This review aims to outline the pathophysiology of TIC and evaluate both established and emerging management strategies. A thorough literature review was made with a specific emphasis on articles discussing the molecular mechanisms of trauma-induced coagulopathy. We utilized PubMed, Scopus, and Web of Science with the main search terms "trauma-induced coagulopathy", "molecular mechanisms", and "coagulation pathways".
创伤仍然是成人死亡和残疾的主要原因,约20%的死亡是由于难治性出血造成的。创伤性凝血病(TIC)是一种复杂的止血障碍,其特征是凝血反应异常,可表现为低凝状态,导致出血过多,或高凝状态,导致血栓栓塞事件和多器官衰竭。早期诊断和纠正低凝可能挽救生命。目前治疗TIC的做法是使用血液成分替代凝血因子,以及用氨甲环酸对抗增强的纤溶,并结合损害控制策略。然而,对TIC发展过程中涉及的几种机制的更好理解可能为有针对性的治疗提供空间,并改善临床结果。本综述旨在概述TIC的病理生理学,并评估现有的和新兴的治疗策略。我们进行了全面的文献回顾,特别强调了讨论创伤性凝血病的分子机制的文章。我们使用PubMed, Scopus和Web of Science,主要搜索词是“创伤性凝血病”,“分子机制”和“凝血途径”。
DiagnosticsBiochemistry, Genetics and Molecular Biology-Clinical Biochemistry
CiteScore
4.70
自引率
8.30%
发文量
2699
审稿时长
19.64 days
期刊介绍:
Diagnostics (ISSN 2075-4418) is an international scholarly open access journal on medical diagnostics. It publishes original research articles, reviews, communications and short notes on the research and development of medical diagnostics. There is no restriction on the length of the papers. Our aim is to encourage scientists to publish their experimental and theoretical research in as much detail as possible. Full experimental and/or methodological details must be provided for research articles.